Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471

Immunology

Volumn 95, Issue 1, 1998, Pages 105-110

  Wheeler, D J ^a   Parveen, S ^a   Pollock, K ^a   Williams, R J ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; [4 (N HYDROXYAMINO) 2 ISOBUTYL 3 (PHENYLTHIOMETHYL)SUCCINYL]PHENYLALNINE N METHYLAMIDE; CD23 ANTIGEN; CD40 ANTIGEN; COLLAGENASE INHIBITOR; CYTOKINE; EDETIC ACID; IMMUNOGLOBULIN E; INTERLEUKIN 4; METALLOPROTEINASE INHIBITOR; MONOCLONAL ANTIBODY; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; STROMELYSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; TONSIL;

B-LYMPHOCYTES; CELLS, CULTURED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-4; METALLOENDOPEPTIDASES; PHENYLALANINE; PROTEASE INHIBITORS; RECEPTORS, IGE; TIME FACTORS; TONSIL;

EID: 0031661781     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00578.x     Document Type: Article

References (20)

1. SUTTON B.J. & GOULD H.J. (1993) The human IgE network. Nature 336, 421.
2. LEBMAN D.A. & COFFMAN R.L. (1988) Interleukin 4 causes isotype switching to IgE in T cell stimulated clonal B cell cultures. J Exp Med 168, 853.
3. NOELLE R.J., LEDBETTER J.A. & ARUFFO A. (1992) CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 13, 431.
4. YU P., KOSCO-VILBOIS M., RICHARDS M., KÖHLER G. & LAMERS M.C. (1994) Negative feedback regulation of IgE synthesis by murine CD23. Nature 369, 753.
5. AUBRY J.-P., POCHON S., GRABER P., JANSEN K.U. & BONNEFOY J.-Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358, 505.
6. DELESPESSE G., SARFATI M., WU C.Y., FOURNIER S. & LETELLIER M. (1992) The low affinity receptor for IgE. Immunol Rev 125,77.
7. YANAGIHARA Y., SAFARTI M., MARSH D., NUTMAN T. & DELESPESSE G. (1990) Serum levels of IgE binding factor in diseases associated with elevated IgE. Clin Exp Allergy 20, 395.
8. MCGEEHAN G.M., BECHERER J.D., BAST R.C. JR. et al. (1994) Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370, 558.
9. ISHIZAKA A., SAKIYAMA M., NAKANISHI M. et al. (1990) The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clin Exp Immunol 79, 392.
10. SAXON A., FELDHAUS J. & ROBINS R.A. (1976) Single step separation of human T and B cells using AET treated SRBC rosettes. J Immunol Methods 12, 285.
11. WHEELER D.J., ROBINS R.A., PRITCHARD D.I., BUNDICK R.V. & SHAKIB F. (1996) Peripheral blood based T cell-containing and T cell-depleted culture systems for human IgE synthesis; the role of T cells. Clin Exp Allergy 26, 28.
12. BONNEFOY J.Y., SHIELDS J. & MERMOD J.-J. (1990) Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc (RII monoclonal antibodies. Eur J Immunol 20, 139.
13. FLORES-ROMO L., SHIELDS J., HUMBERT Y. et al. (1993) Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261, 1038.
14. CHRISTIE G., BARTON A., BOLOGNESE B. et al. (1997) IgE secretion is attenuated by an an inhibitor of proteolytic processing of CD23 (FcεRII). Eur J Immunol 27, 3228.
15. GHADERI A.A., JONES V.M. & STANWORTH D.R. (1991) Affinity-purified soluble FcεRII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism. Immunol Lett 27, 113.
16. BANSAL A., ROBERTS T., HAY E.M., KAY R., PUMPHREY R.S. & WILSON P.B. (1992) Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus. Clin Exp Immunol 89, 452.
17. KAISERLIAN D., LACHAUX A., GROSJEAN I., GRABER P. & BONNEFOY J.-Y. (1993) Intestinal epithelial cells express the CD23/FcεRII molecule: enhanced expression in enteropathics. Immunology 80, 90.
18. YANO N., MIYAZAKI M., ENDOH M. et al. (1992) Increase of CD23-positive cells in peripheral blood from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis. Nephron 60, 404.
19. HELLEN E.A., ROWLANDS D.C., HANSEL T.T., KITAS G.D. & CROCKER J. (1991) Immunoohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis. J Clin Pathol 44, 293.
20. PLATER-ZYBERK C. & BONNEFOY J.-Y. (1995) Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nature Med 1, 781.